MoneyWorks4Me

Hikal passes ANVISA’s GMP audit for Jigani unit

17 Jun 2025 Evaluate

Hikal has successfully passed the Brazilian Health Regulatory Agency’s (ANVISA) Good Manufacturing Practices (GMP) audit for its manufacturing unit located at Jigani in Bengaluru, Karnataka. The inspection, carried out by ANVISA, Brazil GMP, was for multiple API’s which occurred from April 14 to April 18, 2025. 

Hikal is engaged in R&D, manufacturing and marketing of fine chemicals for the Pharmaceutical and Agrochemical industries.

Peers
Company Name CMP
Sun Pharma. Inds. 1853.50
Dr. Reddys Labs. 1202.80
Cipla 1397.20
Lupin 2090.00
Zydus Lifesciences 1202.00
View more..